BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 14657205)

  • 1. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.
    Sun GY; Xu J; Jensen MD; Simonyi A
    J Lipid Res; 2004 Feb; 45(2):205-13. PubMed ID: 14657205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists.
    Sun GY; Xu J; Jensen MD; Yu S; Wood WG; González FA; Simonyi A; Sun AY; Weisman GA
    Mol Neurobiol; 2005; 31(1-3):27-41. PubMed ID: 15953810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipases A2 and inflammatory responses in the central nervous system.
    Sun GY; Shelat PB; Jensen MB; He Y; Sun AY; Simonyi A
    Neuromolecular Med; 2010 Jun; 12(2):133-48. PubMed ID: 19855947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release.
    Han WK; Sapirstein A; Hung CC; Alessandrini A; Bonventre JV
    J Biol Chem; 2003 Jun; 278(26):24153-63. PubMed ID: 12676927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secretory phospholipase A2 and its role in oxidative stress and inflammation].
    Chalimoniuk M
    Postepy Biochem; 2012; 58(2):204-8. PubMed ID: 23214144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diversity of phospholipases A2 and their functions].
    Bereziat G
    C R Seances Soc Biol Fil; 1996; 190(4):409-16. PubMed ID: 8952891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain phospholipases A2: a perspective on the history.
    Farooqui AA; Horrocks LA
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):161-9. PubMed ID: 15253885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.
    Muralikrishna Adibhatla R; Hatcher JF
    Free Radic Biol Med; 2006 Feb; 40(3):376-87. PubMed ID: 16443152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2 (PLA2) activity in gerbil brain: characterization of cytosolic and membrane-associated forms and effects of ischemia and reperfusion on enzymatic activity.
    Bonventre JV; Koroshetz WJ
    J Lipid Mediat; 1993; 6(1-3):457-71. PubMed ID: 8358004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.
    Sun GY; Chuang DY; Zong Y; Jiang J; Lee JC; Gu Z; Simonyi A
    Mol Neurobiol; 2014 Aug; 50(1):6-14. PubMed ID: 24573693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2.
    Murakami M; Shimbara S; Kambe T; Kuwata H; Winstead MV; Tischfield JA; Kudo I
    J Biol Chem; 1998 Jun; 273(23):14411-23. PubMed ID: 9603953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.
    Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS
    Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipases A2 in ischemic and toxic brain injury.
    Sapirstein A; Bonventre JV
    Neurochem Res; 2000 May; 25(5):745-53. PubMed ID: 10905638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and other lipid mediators in Alzheimer's disease.
    Bazan NG; Colangelo V; Lukiw WJ
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():197-210. PubMed ID: 12432919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2, oxidative stress, and neurodegeneration in binge ethanol-treated organotypic slice cultures of developing rat brain.
    Moon KH; Tajuddin N; Brown J; Neafsey EJ; Kim HY; Collins MA
    Alcohol Clin Exp Res; 2014 Jan; 38(1):161-9. PubMed ID: 23909864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid release from NIH 3T3 cells by group-I phospholipase A2: involvement of a receptor-mediated mechanism.
    Xing M; Miele L; Mukherjee AB
    J Cell Physiol; 1995 Dec; 165(3):566-75. PubMed ID: 7593236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phospholipase A2: characteristics and function].
    Sedláková A; Kohút A
    Cesk Fysiol; 1998 Sep; 47(3):95-103. PubMed ID: 9748759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A2.
    Murakami M; Kudo I
    J Biochem; 2002 Mar; 131(3):285-92. PubMed ID: 11872155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase A2 and its role in brain tissue.
    Farooqui AA; Yang HC; Rosenberger TA; Horrocks LA
    J Neurochem; 1997 Sep; 69(3):889-901. PubMed ID: 9282910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.